AMG 319: Phase II started

Cancer Research UK (London, U.K.) began a double-blind, placebo-controlled, U.K. Phase II trial to evaluate 400 mg oral AMG 319 once daily for 21-30 days prior to resection in up to 54 patients. Canc...